Correlation of severity & clinical outcomes of COVID-19 with virus variants : A prospective, multicentre hospital network study
Copyright © 2024 Copyright: © 2024 Indian Journal of Medical Research..
BACKGROUND OBJECTIVES: The clinical course of COVID-19 and its prognosis are influenced by both viral and host factors. The objectives of this study were to develop a nationwide platform to investigate the molecular epidemiology of SARS-CoV-2 (Severe acute respiratory syndrome Corona virus 2) and correlate the severity and clinical outcomes of COVID-19 with virus variants.
METHODS: A nationwide, longitudinal, prospective cohort study was conducted from September 2021 to December 2022 at 14 hospitals across the country that were linked to a viral sequencing laboratory under the Indian SARS-CoV-2 Genomics Consortium. All participants (18 yr and above) who attended the hospital with a suspicion of SARS-CoV-2 infection and tested positive by the reverse transcription-PCR method were included. The participant population consisted of both hospitalized as well as outpatients. Their clinical course and outcomes were studied prospectively. Nasopharyngeal samples collected were subjected to whole genome sequencing to detect SARS-CoV-2 variants.
RESULTS: Of the 4972 participants enrolled, 3397 provided samples for viral sequencing and 2723 samples were successfully sequenced. From this, the evolution of virus variants of concern including Omicron subvariants which emerged over time was observed and the same reported here. The mean age of the study participants was 41 yr and overall 49.3 per cent were female. The common symptoms were fever and cough and 32.5 per cent had comorbidities. Infection with the Delta variant evidently increased the risk of severe COVID-19 (adjusted odds ratio: 2.53, 95% confidence interval: 1.52, 4.2), while Omicron was milder independent of vaccination status. The independent risk factors for mortality were age >65 yr, presence of comorbidities and no vaccination.
INTERPRETATION CONCLUSIONS: The authors believe that this is a first-of-its-kind study in the country that provides real-time data of virus evolution from a pan-India network of hospitals closely linked to the genome sequencing laboratories. The severity of COVID-19 could be correlated with virus variants with Omicron being the milder variant.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:159 |
|---|---|
| Enthalten in: |
The Indian journal of medical research - 159(2024), 1 vom: 01. Jan., Seite 91-101 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 06.03.2024 Date Revised 22.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4103/ijmr.ijmr_1041_23 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368350614 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368350614 | ||
| 003 | DE-627 | ||
| 005 | 20240323000740.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240213s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/ijmr.ijmr_1041_23 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM368350614 | ||
| 035 | |a (NLM)38344919 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wadhwa, Komal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correlation of severity & clinical outcomes of COVID-19 with virus variants |b A prospective, multicentre hospital network study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.03.2024 | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Copyright: © 2024 Indian Journal of Medical Research. | ||
| 520 | |a BACKGROUND OBJECTIVES: The clinical course of COVID-19 and its prognosis are influenced by both viral and host factors. The objectives of this study were to develop a nationwide platform to investigate the molecular epidemiology of SARS-CoV-2 (Severe acute respiratory syndrome Corona virus 2) and correlate the severity and clinical outcomes of COVID-19 with virus variants | ||
| 520 | |a METHODS: A nationwide, longitudinal, prospective cohort study was conducted from September 2021 to December 2022 at 14 hospitals across the country that were linked to a viral sequencing laboratory under the Indian SARS-CoV-2 Genomics Consortium. All participants (18 yr and above) who attended the hospital with a suspicion of SARS-CoV-2 infection and tested positive by the reverse transcription-PCR method were included. The participant population consisted of both hospitalized as well as outpatients. Their clinical course and outcomes were studied prospectively. Nasopharyngeal samples collected were subjected to whole genome sequencing to detect SARS-CoV-2 variants | ||
| 520 | |a RESULTS: Of the 4972 participants enrolled, 3397 provided samples for viral sequencing and 2723 samples were successfully sequenced. From this, the evolution of virus variants of concern including Omicron subvariants which emerged over time was observed and the same reported here. The mean age of the study participants was 41 yr and overall 49.3 per cent were female. The common symptoms were fever and cough and 32.5 per cent had comorbidities. Infection with the Delta variant evidently increased the risk of severe COVID-19 (adjusted odds ratio: 2.53, 95% confidence interval: 1.52, 4.2), while Omicron was milder independent of vaccination status. The independent risk factors for mortality were age >65 yr, presence of comorbidities and no vaccination | ||
| 520 | |a INTERPRETATION CONCLUSIONS: The authors believe that this is a first-of-its-kind study in the country that provides real-time data of virus evolution from a pan-India network of hospitals closely linked to the genome sequencing laboratories. The severity of COVID-19 could be correlated with virus variants with Omicron being the milder variant | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Malik, Shilpa |e verfasserin |4 aut | |
| 700 | 1 | |a Balaji, Srinigila |e verfasserin |4 aut | |
| 700 | 1 | |a Thiruvengadam, Ramachandran |e verfasserin |4 aut | |
| 700 | 1 | |a Bashyam, Murali Dharan |e verfasserin |4 aut | |
| 700 | 1 | |a Bhattacharya, Prasanta Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Behera, Bijayini |e verfasserin |4 aut | |
| 700 | 1 | |a Bhardwaj, Pankaj |e verfasserin |4 aut | |
| 700 | 1 | |a Biswas, Nidhan K |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Asim |e verfasserin |4 aut | |
| 700 | 1 | |a Dey, Anindya |e verfasserin |4 aut | |
| 700 | 1 | |a Dhotre, Dhiraj |e verfasserin |4 aut | |
| 700 | 1 | |a Dias, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Dubey, Pankaj |e verfasserin |4 aut | |
| 700 | 1 | |a Dutta, Shreelekha |e verfasserin |4 aut | |
| 700 | 1 | |a Gadepalli, Ravisekhar |e verfasserin |4 aut | |
| 700 | 1 | |a Gosain, Mudita |e verfasserin |4 aut | |
| 700 | 1 | |a Goud, Kalal Iravaty |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Neeraj Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Nitesh |e verfasserin |4 aut | |
| 700 | 1 | |a Jana, Pradipta |e verfasserin |4 aut | |
| 700 | 1 | |a Jena, Deepak |e verfasserin |4 aut | |
| 700 | 1 | |a John, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Karunanidhi, Arunkumar |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, S Muhammad Salim |e verfasserin |4 aut | |
| 700 | 1 | |a Khattar, Sahil |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, Abhilash Prabhakar Kundavaram |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Shakti |e verfasserin |4 aut | |
| 700 | 1 | |a Maitra, Arindam |e verfasserin |4 aut | |
| 700 | 1 | |a Modi, Nikhil |e verfasserin |4 aut | |
| 700 | 1 | |a Moorthy, Mahesh |e verfasserin |4 aut | |
| 700 | 1 | |a Nagaraj, Savitha |e verfasserin |4 aut | |
| 700 | 1 | |a Palakodeti, Dasaradhi |e verfasserin |4 aut | |
| 700 | 1 | |a Pandey, Anil Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Pandey, Aparna |e verfasserin |4 aut | |
| 700 | 1 | |a Raghav, Sunil Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Ramasubban, Suresh |e verfasserin |4 aut | |
| 700 | 1 | |a Raghavan, Sreevatsan |e verfasserin |4 aut | |
| 700 | 1 | |a Harikrishnan, S |e verfasserin |4 aut | |
| 700 | 1 | |a Krishnamoorthy, S |e verfasserin |4 aut | |
| 700 | 1 | |a Selvamurugan, Selvaraj |e verfasserin |4 aut | |
| 700 | 1 | |a Sardana, Raman |e verfasserin |4 aut | |
| 700 | 1 | |a Shouche, Yogesh |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Akanksha |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Arvind Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Ramasubramaniyan, V |e verfasserin |4 aut | |
| 700 | 1 | |a Yadav, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Zahoor, Danish |e verfasserin |4 aut | |
| 700 | 1 | |a Narreddy, Suneetha |e verfasserin |4 aut | |
| 700 | 1 | |a Bhatnagar, Shinjini |e verfasserin |4 aut | |
| 700 | 1 | |a Wadhwa, Nitya |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Bhabatosh |e verfasserin |4 aut | |
| 700 | 1 | |a Garg, Pramod Kumar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Indian journal of medical research |d 1945 |g 159(2024), 1 vom: 01. Jan., Seite 91-101 |w (DE-627)NLM000030619 |x 0971-5916 |7 nnns |
| 773 | 1 | 8 | |g volume:159 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:91-101 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/ijmr.ijmr_1041_23 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 159 |j 2024 |e 1 |b 01 |c 01 |h 91-101 | ||